Head and neck squamous cell carcinoma in 13 patients with fanconi anemia after hematopoietic stem cell transplantation

Cancer

Volumn 113, Issue 12, 2008, Pages 3315-3322

  Masserot, Caroline ^a   De Latour, Régis Peffault ^a   Rocha, Vanderson ^a   Leblanc, Thierry ^a   Rigolet, Arnaud ^a   Pascal, Francis ^a   Janin, Anne ^a   Soulier, Jean ^a,b,c   Gluckman, Eliane ^a,b   Socié, Gérard ^a,b,c  

^a SAINT LOUIS HOSPITAL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c INSERM   (France)

Author keywords

Fanconi anemia; Head and neck; Hematopoietic stem cell transplantation; Squamous cell carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; METHOTREXATE; STEROID; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER GROWTH; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CERVICAL LYMPH NODE; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CRYOTHERAPY; DISEASE COURSE; DISEASE FREE SURVIVAL; DRUG MEGADOSE; FANCONI ANEMIA; FEMALE; FOLLOW UP; HEAD AND NECK CARCINOMA; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LOW DRUG DOSE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MALE; MOUTH CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; TUMOR BIOPSY; WHOLE BODY RADIATION;

ADULT; CARCINOMA, SQUAMOUS CELL; CHILD; CHILD, PRESCHOOL; FANCONI ANEMIA; FEMALE; GRAFT VS HOST DISEASE; HEAD AND NECK NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; PROGNOSIS; TRANSPLANTATION CONDITIONING;

EID: 57649129523     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23954     Document Type: Article

References (35)

1. Tischkowitz M, Dokal I. Fanconi anaemia and leukaemia - clinical and molecular aspects. Br J Haematol. 2004;126:176-191.
2. Alter BP. Fanconi's anemia. Current concepts. Am J Pediatr Hematol Oncol. 1992;14:170-176.
3. Butturini A, Gale RP, Verlander PC, Adler-Brecher B, Gillio AP, Auerbach AD. Hematologic abnormalities in Fanconi anemia: an International Fanconi Anemia Registry study. Blood. 1994;84:1650-1655.
4. Gluckman E, Auerbach AD, Horowitz MM, et al. Bone marrow transplantation for Fanconi anemia. Blood. 1995;86:2856-2862.
5. D'Andrea AD, Grompe M. The Fanconi anaemia/BRCA pathway. Nat Rev Cancer. 2003;3:23-34.
6. Venkitaraman AR. A growing network of cancer-susceptibility genes. N Engl J Med. 2003;348:1917-1919.
7. Venkitaraman AR. Tracing the network connecting BRCA and Fanconi anaemia proteins. Nat Rev Cancer. 2004;4:266-276.
8. Levitus M, Joenje H, de Winter JP. The Fanconi anemia pathway of genomic maintenance. Cell Oncol. 2006;28:3-29.
9. Alter BP, Greene MH, Velazquez I, Rosenberg PS. Cancer in Fanconi anemia. Blood. 2003;101:2072.
10. Alter BP. Fanconi's anemia and malignancies. Am J Hematol. 1996;53:99-110.
11. Kutler DI, Auerbach AD, Satagopan J, et al. High incidence of head and neck squamous cell carcinoma in patients with Fanconi anemia. Arch Otolaryngol Head Neck Surg. 2003;129:106-112.
12. Rosenberg PS, Greene MH, Alter BP. Cancer incidence in persons with Fanconi anemia. Blood. 2003;101:822-826.
13. D'Andrea AD. The Fanconi road to cancer. Genes Dev. 2003;17:1933-1936.
14. Rosenberg PS, Socie G, Alter BP, Gluckman E. Risk of head and neck squamous cell cancer and death in patients with Fanconi anemia who did and did not receive transplants. Blood. 2005;105:67-73.
15. Socie G, Scieux C, Gluckman E, et al. Squamous cell carcinomas after allogeneic bone marrow transplantation for aplastic anemia: further evidence of a multistep process. Transplantation. 1998;66:667-670.
16. Guardiola P, Socie G, Li X, et al. Acute graft-versus-host disease in patients with Fanconi anemia or acquired aplastic anemia undergoing bone marrow transplantation from HLA-identical sibling donors: risk factors and influence on outcome. Blood. 2004;103:73-77.
17. Deeg HJ, Socie G, Schoch G, et al. Malignancies after marrow transplantation for aplastic anemia and fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients. Blood. 1996;87:386-392.
18. Socie G, Devergie A, Girinski T, et al. Transplantation for Fanconi's anaemia: long-term follow-up of fifty patients transplanted from a sibling donor after low-dose cyclophosphamide and thoraco-abdominal irradiation for conditioning. Br J Haematol. 1998;103:249-255.
19. Socie G, Henry-Amar M, Bacigalupo A, et al. Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party. N Engl J Med. 1993;329:1152-1157.
20. Socie G, Curtis RE, Deeg HJ, et al. New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia. J Clin Oncol. 2000;18:348-357.
21. Maarek O, Jonveaux P, Le Coniat M, Derre J, Berger R. Fanconi anemia and bone marrow clonal chromosome abnormalities. Leukemia. 1996;10:1700-1704.
22. Guardiola P, Socie G, Pasquini R, et al. Allogeneic stem cell transplantation for Fanconi Anaemia. Severe Aplastic Anaemia Working Party of the EBMT and EUFAR. European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 1998;21(suppl 2):S24-S27.
23. Shulman HM, Sullivan KM, Weiden PL, et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med. 1980;69:204-217.
24. Thomas E, Storb R, Clift RA, et al. Bone-marrow transplantation (first of 2 parts). N Engl J Med. 1975;292:832-843.
25. Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation. 1974;18:295-304.
26. Millen FJ, Rainey MG, Hows JM, Burton PA, Irvine GH, Swirsky D. Oral squamous cell carcinoma after allogeneic bone marrow transplantation for Fanconi anaemia. Br J Haematol. 1997;99:410-414.
27. Pignon JP, Bourhis J, Domenge C, Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: 3 meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet. 2000;355:949-955.
28. Vincent T, DeVita SH, Rosenberg SA. Cancer: Principles and Practice of Oncology. 6th ed. Philadelphia: Lippincott-Raven; 2001.
29. Berger R, Bernheim A, Gluckman E, Gisselbrecht C. In vitro effect of cyclophosphamide metabolites on chromosomes of Fanconi anaemia patients. Br J Haematol. 1980;45:565-568.
30. Gluckman E, Devergie A, Dutreix J. Radiosensitivity in Fanconi anaemia: application to the conditioning regimen for bone marrow transplantation. Br J Haematol. 1983;54:431-440.
31. Alter BP, Joenje H, Oostra AB, Pals G. Fanconi anemia: adult head and neck cancer and hematopoietic mosaicism. Arch Otolaryngol Head Neck Surg. 2005;131:635-639.
32. Vora HH, Trivedi TI, Shukla SN, Shah NG, Goswami JV, Shah PM. p53 expression in leukoplakia and carcinoma of the tongue. Int J Biol Markers. 2006;21:74-80.
33. Sudbo J. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med. 2001;345:376-377.
34. Kutler DI, Wreesmann VB, Goberdhan A, et al. Human papillomavirus DNA and p53 polymorphisms in squamous cell carcinomas from Fanconi anemia patients. J Natl Cancer Inst. 2003;95:1718-1721.
35. de la Fuente J, Reiss S, McCloy M, et al. Non-TBI stem cell transplantation protocol for Fanconi anaemia using HLAcompatible sibling and unrelated donors. Bone Marrow Transplant. 2003;32:653-656.